We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-4.25 | -13.93% | 26.25 | 26.00 | 26.50 | 30.50 | 25.75 | 30.50 | 2,484,275 | 16:23:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.19M | -0.0469 | -5.60 | 17.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/4/2024 21:56 | They wouldn't be one bit bothered if it went to 15p?! They would probably be driving to the BODs homes demanding resignations! Can't see it worth 5p to be honest... | wolfofwallstreets | |
25/4/2024 21:49 | Celtic007, obviously on the Special Brew LOL, but in all seriousness, it shows them in their true colours? Real nasty, bad-mannered, ill-bred, ill-mannered, impertinent people! Last post from me tonight. Cheers | peaceandlove | |
25/4/2024 21:15 | Interesting comments iamhappy. I agree with the little data available. I also feel Sareum are at the last throw of the dice stage. Let's be honest even the happy clappers would agree. If it wasn't for the shareholders bailing Sareum out, it'd already be over. The happy clappers blame the MHRA for Sareum not being able to conduct a clinical trial in the UK. I suspect the MHRA felt the novel formulation was not a sufficient innovation to expose fit and healthy volunteer-patients to the risks of the clinical trial. I don't know about the safety data, but I see no evidence from anyone that shows a large pharmaceutical will want to take this one on. I'm not going to accuse the board of stringing it along, however, there's so many companies that have taken advantage of shareholders investing in their company. My personal opinion is Sareum will not succeed in licensing any of their products. 20 years to this point and nothing. | peaceandlove | |
25/4/2024 20:50 | There is so little data on 1801 to make any sort of rational investment decision, no wonder any potential licencees want to see positive efficacy data before they will open discussions Why no Phase 1b "now that is the right question" if they don't announce end of the mad cohorts soon with a blinding RNS Run | iamhappy1 | |
25/4/2024 20:21 | This guy below 👇 on LSE for the last 5 years or so always puts up billion dollar deals and takeovers. I decided to look at some of his other posts and guess what he states the same rubbish in other sectors for other small cap companies on Aim. I think he's actually bearish about all the stocks he ramps and makes money shorting them or he needs to be sectioned 🤣😆 Brighty1 Posts: 2,563 Price: 27.25 No Opinion RE: Daily fluctuations don't bother investors with a medium term strategyToday 14:51 Exactly, I was buying these at 0.4p via the Primary Bid offer in June 2019 and had been snapping them up for below .3p in 2015. It's interesting to note that the share price then was pretty comparable to where it is today, since the 50-1 consolidation of shares. If we get good news on the P1a trial this will soar back up again as it has done in the past. Maybe not by your 4,600% example but if we do get a significant licencing deal from a major player then 200p to 300p is not un-reasonable.... Good luck, Brighty | peaceandlove | |
25/4/2024 20:12 | What happened with WIP? He was always bullish. I missed that one. | peaceandlove | |
25/4/2024 19:38 | How naieve are the lse posters... The last few days..the share price rises..that's us on our way.. month of the rerate..thoth knew this would happen etc... 2 days of falls.. AiM is corrupt..what's going on here..I better write to Tim... Clowns | wolfofwallstreets | |
25/4/2024 17:21 | It stinks like a bloody sperm bank in here. It begs the question; Has peaceandlove burped or has Wolfofwallstreets farted? 🤔 | norma_stitts | |
25/4/2024 16:38 | Stealive.. I would wait for when this drops to 5p a share to buy... | wolfofwallstreets | |
25/4/2024 15:50 | 30% drop since Wednesday.. L2 HorrificallyHenry? | wolfofwallstreets | |
25/4/2024 15:24 | Time to top up gents. | stealive | |
25/4/2024 15:19 | Sadoldgit time and time again just makes himself look a fool.. I don't know anything of the science or the compounds.. but I know a red line falling when I see it.. | wolfofwallstreets | |
25/4/2024 14:51 | I see this dropping below 20p over the next week or so, perhaps sooner. This time there can be no blame on RF. I wonder whose fault it'll be? Where's acckers and barkbooo gone? They were giving it large yesterday morning when the share price opened 10% up LOL. As per usual little investors that know nothing about investing in small cap. I have to also laugh at the muppets over on LSE. Most of them see nothing but clear blue sky ahead - below a few snippets from Mr Git from exactly a week ago. sadoldgit Premium Member Posted in: SAR Posts: 4,147 Price: 26.75 No Opinion Trading volume.18 Apr 2024 20:14 8.2 million shares traded today. Can safely say good bye to the 20's tomorrow, for good. On a positive RNS you can kiss the 30's goodbye also. Dosaging been carried out within the therapeutic area which l believe exceeded Sareums expectations with regards to uptake. HAHAHA what does he know? | peaceandlove | |
25/4/2024 14:19 | L2 Henry? X | wolfofwallstreets | |
25/4/2024 11:05 | HorrificallyHenry how's L2 looking. | wolfofwallstreets | |
25/4/2024 11:03 | Peace...love the glengarry reference... classic! Actually laughing at that.. Sadoldgit as shelly levine.. | wolfofwallstreets | |
25/4/2024 09:26 | I see the ‘Wealth manager’ 😂😂 25-Apr-24 08:52:12 29.00 3 Buy* 0.87 O It’ll be eating beans on toast from the food bank for the foreseeable. Oops, my mistake. It did that anyway. They put edges on 20 pence coins so you can get them out of the hands of the tight-fisted Scots by using a spanner. | norma_stitts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions